FDA Recalls For Dec. 25, 2013
This article was originally published in The Tan Sheet
Executive Summary
Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
You may also be interested in...
Litigation Follows OTC Eye Drops Recall Due To Bacteria Strain Not Previously Seen In US
Following a recall earlier in February of EzriCare’s and Delsam’s OTC artificial tears due to potential bacterial contamination, plaintiffs’ bar steps in with first of what may be multiple lawsuits. CDC says drug-resistant strain of Pseudomonas aeruginosa bacteria not previously seen in US.
Sterility Concerns Spark Altaire's CVS, Walmart, Walgreens Eye Drop Recalls
Altaire "is initiating the recall due to management concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility," firm says in its recall announcements.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”